Arterial smooth muscle cell (SMC) proliferation is thought to be an essential aspect of the development of human atherosclerotic lesions. In this study we posed the question, could a growth factor gene be transcriptionally active in atherosclerotic tissue? We found that transcripts from the sis gene, which encodes one of the two chains of platelet-derived growth factor, were present in surgically removed human carotid artery lesions at levels 5-fold greater than the low level of constitutive expression detected in normal artery. This demonstrates that a growth factor could be synthesized endogenously within human atherosclerotic lesions. Although atherosclerotic lesions are composed predominantly of SMC, large numbers of infiltrating macrophages, T cells, and endothelial cells can also be present, raising the possibility that one of these secondary cell types, rather than SMC, could be responsible for the sis transcripts. Human macrophages activated in culture contained 2-to 4-fold more sis RNA, per jig of total cellular RNA, than lesions, whereas T cells activated in culture did not contain significant levels. Cultured human endothelial cells expressed sis transcripts at higher levels than macrophages. Since human arterial SMC in culture express receptors for and are mitogenically responsive to platelet-derived growth factor, transcription of the sis gene by cells within lesions, whether these cells are SMC themselves, macrophages, endothelial cells, or another cell type, suggests that an autocrine and/or paracrine proliferative mechanism is important in the pathogenesis of atherosclerosis.
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Human atherosclerotic lesions (or plaques) develop by gradual accumulation of cells and extracellular material at focal points within the intima, the thin inner lining, of large-and medium-sized arteries. Factors controlling the migration and proliferation of smooth muscle cells (SMC), the most prevalent cell type within lesions, are thought to be key elements in the initiation and progression of the disease (1) .
To explore the possibility that a growth factor might be produced endogenously within atherosclerotic plaques, we extracted RNA from clinically obstructive, surgically removed carotid endarterectomy (CEA) specimens and assayed for the presence of transcripts from the sis gene, which encodes the B chain ofplatelet-derived growth factor (PDGF-B) (2) , by blot hybridization. We found sis RNA levels were elevated in CEA specimens 5-fold above the constitutive baseline level present in normal artery, suggesting that the SMC proliferation occurring in atherosclerosis could be endogenously driven. A preliminary report of some of these results was made in abstract form (3) .
In addition to SMC, human atherosclerotic plaques are generally populated by significant numbers of infiltrating cells, including large numbers of macrophages and T cells (4) , as well as smaller numbers of other leukocytes and endothelial cells. Since these cell types are capable of elaborating various mitogenic and chemotactic substances, their presence complicates attempts to define stimuli responsible for SMC migration and proliferation during atherogenesis (5) . In particular, macrophages (6, 7, 25) and endothelial cells (8) can actively transcribe the sis gene and can produce PDGF-like proteins in culture (6, 9).
Here we report that sis RNA levels in cultured macrophages and endothelial cells were higher than levels in lesions, per ,ug of total cellular RNA. This finding raises the possibility that one or both of these cell types could be responsible for much, or even all, of the sis RNA detected in CEA lesions. On the other hand, we found that cultured rat arterial SMC also can express the sis gene. We conclude, therefore, that consideration should be given to the possibility that the SMC within lesions may themselves express the sis gene and that SMC proliferation in atherosclerosis could have an autocrine stimulatory component.
MATERIALS AND METHODS
Cells. The source and culture of bovine aortic endothelial (BAE) cells, human umbilical vein endothelial (HUVE) cells, fetal human aortic SMC, and rat aortic SMC (8, 10) . Elutriated peripheral blood monocytes from a normal human donor were provided by Dave Madtes and Russell Ross; the culture and activation of these cells by Con A at 10 ,ug/ml have been described (12) . Activated T cells and B cells were prepared as follows: peripheral blood mononuclear cells were isolated by banding over Ficoll-Paque (specific gravity, 1.077); macrophages were selectively removed by adherence to tissue culture flasks (Falcon) and the resultant T cells and B cells were cultured for 1 day in RPMI 1640 medium with 10% fetal calf serum in the presence of -5% macrophages; then phytohemagglutinin was added at 2 ,.g/ml and the cells were cultured an additional 3 days.
Tissues. The atherosclerotic tissues assayed were CEA specimens surgically removed from the bifurcation of the carotid artery. Normal aorta and carotid artery were obtained from a 55-year-old male accident victim at autopsy performed 4 hr postmortem. Female rhesus monkeys (Macaca mulatta) were between 7 and 20 years old. Sprague-Dawley rats were either 2 weeks old (pup) or 3 months old (adult).
RNA Purification. RNA was extracted from freshly obtained intact tissues by the technique of Chirgwin et al. (13) with modifications: specimens were frozen in liquid nitrogen, stored at -70°C, pulverized under liquid nitrogen, and then dispersed by Polytron in guanidine isothiocyanate; the solution was cleared by centrifugation at 15,000 x g for 10 min;
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Medical Sciences: Barrett and Benditt pelleting was performed twice, first through a 1.5 g/cm3 cushion to obtain total nucleic acids, then through a 1.80-1.85 g/cm3 cushion to obtain purified RNA. RNA from cultured cells was prepared by LiCl precipitation (14) .
Gel Electrophoresis, Transfer to Membranes, and Hybridization. RNA was denatured and electrophoresed in phosphate/formaldehyde denaturing agarose gels (10 (8) and transformed cell lines. Oligo(dT)-cellulose chromatography performed on one specimen prior to RNA transfer analysis confirmed that the message was polyadenylylated (Fig. 1, case 3 ). These RNA transfer blot results demonstrated that the sis gene was transcriptionally active in each of these five clinically significant carotid artery atherosclerotic lesions.
As a control for sis expression in CEA lesions, RNA was extracted from the aorta of a 55-year-old accident victim and similarly assayed. This aorta appeared normal by visual inspection and light microscopy. A 3.7-kb band, of identical size to that found in the CEA specimens, but of lesser intensity, was detected ( Fig. 1, ctrl) . The first two CEA specimens shown in Fig. 1 (cases 1 and 2) gave signals that were 25% and 28%, respectively, the intensity per ,ug of total cellular RNA, of the signal obtained from a BAE cell RNA standard run in all experiments and used as a common control (see Materials and Methods and Table 1 , group A). In comparison, normal aorta gave a signal that was 5% of the BAE standard, indicating that the level of sis gene mRNA was elevated 5-fold in these CEA lesions above the level of expression in normal aorta.
To confirm the quantitative character of these results, we extracted RNA from CEA lesions obtained from five additional patients and from two normal control arteries. We assayed these RNAs for the presence of sis transcripts by dot blot analysis (see Fig. 2A ). Signals from the two control vessels, an aorta and a carotid artery obtained from the same individual, were low and of similar intensity. The five CEA lesions gave signals ranging from 5-to 10-fold more intense than these normal controls, as determined by using densitometry (Table 1 , group A). Rehybridization of this membrane with an actin probe demonstrated that approximately equal amounts of RNA had been loaded for each specimen (see Fig. 2B ). This analysis confirmed (i) the constitutive presence of sis transcripts in normal artery and (ih) the 5-fold elevation of sis transcripts in carotid artery atherosclerotic lesions.
Our finding that sis gene transcripts were elevated in each of 10 atherosclerotic plaques assayed suggests that a growth factor may well be produced endogenously within the lesion itself. Our second finding, that sis mRNA is present in normal human arteries at low constitutive levels, was unexpected and suggests that PDGF-B has a role in the maintenance of the normal vessel wall.
To support our conclusion that the low-level sis expression we detected in control vessels is indeed normal and to determine if this occurs in other mammals, we assayed RNA extracted from adult rhesus monkey aorta and carotid artery, adult cow aorta, 3-month-old (adult) rat aorta and carotid artery, and 2-week-old (pup) rat aorta. By RNA transfer blot hybridization analysis we detected sis RNA bands at low levels in all samples tested (Table 1, group B) . Representative samples of RNA transfer blot and dot blot data on rhesus monkey and adult rat arteries are shown (Fig. 3) . The sis mRNA detected in the rat is =200 bases shorter than the human and rhesus monkey RNA. The presence of low levels of sis transcripts in all arteries of all species assayed supports our conclusion that the sis RNA detected in control human aorta and carotid artery is indeed constitutive and strengthens the hypothesis that the sis gene plays a role in the maintenance of the normal adult mammalian vessel wall. It should be noted, though, that constitutive expression of the sis gene is not unique to large arteries: sis mRNA is also present at low levels in kidney and heart (data not shown).
In Vitro Assessment of Candidate Cell Types Possibly Responsible for sis (PDGF-B) Gene Transcripts in Atherosclerotic Lesions. Atherosclerotic lesions are complex and in addition to SMC generally include significant numbers of infiltrating mononuclear blood cells and endothelial cells (5) . CEA plaques in particular have been reported to contain 25% macrophages and 25% T cells as determined by immunocytochemistry (4) . The percentage of endothelial cells has not been reported but is probably much less than macrophages, To determine which of these cell types might be considered candidates responsible for the sis transcripts detected in plaques, we assayed macrophages, T cells, and B cells for sis transcription. As previously reported by Martinet et al. (25) , RNA extracted from peripheral blood monocytes immediately after elutriation but before plating did not contain a detectable sis signal, whereas a second aliquot of the same cells cultured for 5 days and then activated with Con A for 24 hr showed a strong 3.7-kb band (Fig. 4 Advanced atherosclerotic lesions have long been recognized to contain areas of small vessel neovascularization (18) . We have reported (8) that endothelial cells contain moderate levels of sis RNA when freshly removed from newborn umbilical vein and that after transfer to culture the levels rise dramatically. Using scanning densitometry, the sis signals detected under these two conditions were determined to be 3-fold and 30-fold, respectively, greater than the average sis signal detected in atherosclerotic plaques (Fig. 4 and Table 1 ,
Finally, the possibility that SMC themselves express the sis gene needs consideration for two reasons: (i) we have found that the sis gene is expressed constitutively in normal arteries of all species examined and (it) rat arterial SMC have been reported to produce PDGF-like proteins in culture (10, 11, 19) . Four offour cultured fetal human aortic SMC isolates showed 3.7-kb sis bands by RNA transfer blot analysis, but the signals were weak, approximately one-fourth the intensity of normal adult human aorta. A representative example is shown (Fig. 4) . In striking contrast to human SMC, RNA extracted from cultured pup rat aortic SMC gave a strong 3.5-kb sis band by RNA transfer analysis, whereas cultured adult rat aortic SMC gave a barely detectable signal (Fig. 4) Macrophages are the most obvious cell type that might account for the majority of sis transcripts in lesions. As demonstrated here, when activated by Con A in culture, they contained 2-to 4-fold higher levels of sis gene transcripts per gg of total RNA than the overall level of sis transcripts detected in plaques. In addition, freshly isolated human alveolar macrophages have been shown to contain sis RNA (7, 8) , indicating they can be transcriptionally active in vivo. Since macrophages are reported to comprise as much as 25% of cells in some lesions (4), it is conceivable that they alone might produce the bulk of sis RNA in CEA specimens. If this is so, it supports the notion that atherosclerotic SMC proliferation could be driven by a paracrine mechanism and emphasizes the significance of macrophage infiltration (5, 21) in the progression, and perhaps even initiation, of atherosclerosis.
We found that human endothelial cells can actively transcribe the sis gene in vivo and in vitro (8) and here demonstrate that sis transcript levels under both of these conditions are higher than the levels detected in CEA lesions. Although these cells do not comprise a large percentage of cells within atherosclerotic lesions, the high level of message production by cultured human endothelial cells raises the possibility that endothelial cells within plaques could play a significant role at strategic locations where neovascularization of lesions occurs.
Leukocytes other than macrophages, principally T cells, are also prevalent in lesions, but our finding that T cells did not contain significant levels of sis mRNA when activated by phytohemagglutinin in culture indicates they are an unlikely candidate to account for the sis mRNA found in vivo.
Of particular interest to us is the possibility that SMC themselves might be transcriptionally active in plaques. We found only very low levels of sis RNA in cultured human SMC. In contrast, we found high levels of sis mRNA in cultured SMC derived from the newborn rat aorta but low levels in cultured SMC derived from the adult rat aorta. These rat data are consistent with published observations of PDGF-like activity produced by cultured SMC from newborn but not adult animals (10) . Interestingly, Walker et al. (11) have recently reported that cultured SMC from the neointima of the balloon-injured rat carotid artery also produce PDGFlike activity, and Nilsson et al. (19) found PDGF-like activity in primary but not later passages of cultured SMC derived from the adult rat aorta. Taken together, these data imply that the ability of rat arterial SMC to synthesize and secrete PDGF is under developmental and, perhaps, other kinds of control. Although we did not find high levels ofsis expression in cultured human fetal SMC, it remains possible that sis expression and production of PDGF by SMC in human plaques could be induced by transcriptional activation of a previously inactive cell or by selection of a constitutively active cell present only as a minority species in the normal adult vessel wall.
Other potential mechanisms for transcriptional activation of the sis gene in the SMC populating atherosclerotic plaques should be considered: for example, activation could be induced by factors secreted from infiltrating cell types, Proc. Natl. Acad. Sci. USA 84 (1987) similar to the induction of sis transcription in AKR-2B cells by transforming growth factor 3 (22) . Alternatively, activation could occur by an event analogous to benign tumor induction, as originally proposed by Benditt and Benditt (23) as an explanation for monoclonality.
Our observation that sis gene transcripts are present at significant levels in human atherosclerotic lesions provides direct evidence that an autocrine and/or paracrine proliferative mechanism could be important in the pathogenesis of atherosclerosis. The variety of cell types present in plaques, three of which we have demonstrated here are capable of activating the sis gene to relatively high levels under particular circumstances, confounds attempts to define this mechanism more precisely at present and underscores the importance of identifying individual transcriptionally active cell types within lesions, preferably using an in situ technique.
If the sis transcripts in human atherosclerotic plaques are contributed only by cells other than SMC, this will support previously proposed paracrine growth factor models for atherogenesis. On the other hand, if SMC in human plaques are transcriptionally active, then SMC proliferation could involve an autocrine PDGF cycle. Induction of an autocrine proliferative cycle could operate in the initiation of lesions and could coincide with the origin of monoclonality. Determining the mechanism by which an autocrine growth factor cycle is induced would then be critically important to understanding the etiology and the progression of human atherosclerosis. The recent finding by Penn et al. (24) of a transfectable element in DNA derived from human atheromatous coronary artery endarterectomy specimens is entirely compatible with this idea.
